Courage Quest” - A Digital Exposure-Focused Intervention for Children with Anxiety: A Randomised Controlled Trial

Not Applicable

• Conditions: Mental health; Mental Health - Anxiety; Anxiety

• Registration Number: ACTRN12623000828628
• Lead Sponsor: niversity of New South Wales

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-08-01
• Last Update Posted: 6 November 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 250

Inclusion Criteria

•Child aged 8 to 12 years
•Child diagnosed with one or more anxiety disorders and/or obsessive-compulsive disorder (as determined on the KSADS-COMP)
•Capacity to answer questions independently or with assistance if needed

Exclusion Criteria

•Child has a diagnosis of major depression (as determined by the KSADS-COMP)
•Child has a primary oppositional defiant disorder or conduct disorder diagnosis that is equal to or greater than their anxiety disorder severity (as determined by the KSADS-COMP)
•Child has a primary attention deficit hyperactivity disorder diagnosis that is greater than their anxiety disorder severity (as determined by the KSADS-COMP)
•Child has a diagnosed intellectual disability (as determined through parent self-report)
•Child is currently receiving CBT-based psychological therapy for anxiety (other than school counsellor support), i.e., seeing a psychologist for anxiety or using a CBT-based program (e.g., Cool Kids or BRAVE) for anxiety (as determined through parent self-report). Note: child will be eligible if they are receiving other types of (i.e., non-CBT-based) psychological treatment
•Child is currently prescribed medication for anxiety (as determined through parent self-report).
•Child is reported to have life-threatening suicidal ideation and/or had serious suicidal ideation in the last month (as determined through parent self-report). A clinician (Dr Francis, Dr Sicouri, Dr Aji, Dr Chen, or Prof Hudson) will also complete a risk assessment follow-up with parents. This follow-up will occur via telephone within 72 hours of the self-report.
•Child must not have participated in the pilot study (ACTRN12623000779673)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in diagnosis of anxiety disorders, as based on the Kiddie Schedule for Affective Disorders and Schizophrenia Child Psychiatric Diagnostic Interview (KSADS-COMP; Townsend et al., 2020) self-report completed by parents[ Baseline, post-completion of 10-week treatment period (primary endpoint), delayed follow-up 10 weeks after 10-week treatment period]